Home  |  Site Map  |  Glossary  | Contact
Aug. 7 QLT Announces Adoption of Advance Notice Policy
Aug. 5 QLT Announces Second Quarter 2014 Results
July 14 QLT Announces Publication in The Lancet of Phase 1b Data for QLT091001 in Leber Congenital Amaurosis due to LRAT or RPE65 Mutations
June 26 Auxilium Pharmaceuticals to Merge with Canadian Biotechnology Company QLT
Copyright 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking
Employee Login